viernes, 22 de mayo de 2020

Gut Bacteria Affecting Parkinson’s Treatment

Gut Bacteria Affecting Parkinson’s Treatment

News-Medical

Dopamine Neurotransmitter

Gut Bacteria Affecting Parkinson’s Treatment

Parkinson’s disease (PD) is treated by levodopa, which is a prodrug capable of crossing the blood-brain barrier before being metabolized to dopamine, a vital neurotransmitter in the brain.
However, certain gut bacteria interfere with this treatment, leading to unpredictable fluctuations in the motor response to levodopa and pushing up the dosage levels unnecessarily.

No hay comentarios:

Publicar un comentario